Pretreatment with controlled-release morphine for pain after hysterectomy

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Postoperative pain management is crucial for patient recovery.
• Optimizing pre-operative analgesia can potentially improve surgical outcomes.

Purpose of the Study:

• To evaluate the efficacy of different controlled-release morphine dosing regimens for prophylactic postoperative pain control.
• To compare a single pre-operative dose versus a prolonged pre-operative regimen against placebo in women undergoing abdominal hysterectomy.

Main Methods:

• Double-blind, randomized controlled trial involving 51 women.
• Three groups: prolonged pre-operative morphine, single pre-operative dose, and placebo.
• Assessed patient-controlled analgesia demands, pain scores, and McGill pain questionnaires post-surgery.

Main Results:

• No significant pain score differences in the first 2 postoperative days across groups.
• Significantly lower pain scores on postoperative days 3 and 4 in the single pre-operative dose group compared to placebo and prolonged regimen groups (p=0.043, p=0.024).
• Fewer and less variable patient-controlled analgesia demands in the single pre-operative dose group.

Conclusions:

• A single pre-operative dose of controlled-release morphine demonstrates a beneficial analgesic effect for postoperative pain after hysterectomy.
• Prolonged pre-operative controlled-release morphine administration offers no additional analgesic advantage over placebo.